The Department of Health issued a buprenorphine guidance document, which focuses on reducing barriers to accessing Medications for Opioid Use Disorder (MOUD). The document includes a frequently asked questions section that addresses inquiries from prescribers and pharmacists about MOUD. It also offers insights on enforcement practices, buprenorphine prescribing, continuity of care and telehealth prescriptions. All questions can be directed to RA-DHRESOURCESERVICE@pa.gov.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.